InSilico Medicine’s $35 Million Series D2 Financing

Davis Polk advised InSilico Medicine in the transaction.InSilico Medicine completed its $35 million Series D2 financing, bringing the total Series D financing to $95 million. The…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Laura Testa

Author: Laura Testa

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here